We examined whether there was an opportunity for us to stagger the developments, without having a detrimental effect on the service improvements that we were keen to make, but that was not possible—not least because the prioritisation at United Kingdom level of the new Marie Curie hospice by one of the major funding partners, Marie Curie Cancer Care, was dependent on funding being accessed at a particular time.